Panagora Asset Management Inc Curis Inc Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $11,538 - $39,492	-16,252 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.31 - $5.13 $17,264 - $38,341	-7,474 Reduced 31.5%	16,252 $39,000
Q4 2021 Feb 10, 2022	BUY	$4.45 - $8.09 $105,580 - $191,943	23,726 New	23,726 $113,000
Q3 2020 Nov 13, 2020	SELL	$0.95 - $1.42 $1,705 - $2,548	-1,795 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$1.74 - $2.83 $82,009 - $133,383	-47,132 Reduced 96.33%	1,795 $4,000
Q2 2019 Aug 09, 2019	SELL	$1.36 - $2.35 $851 - $1,471	-626 Reduced 1.26%	48,927 $91,000
Q4 2018 Feb 14, 2019	BUY	$0.62 - $2.25 $11,750 - $42,642	18,952 Added 61.93%	49,553 $34,000
Q3 2018 Nov 13, 2018	BUY	$1.38 - $1.94 $42,229 - $59,365	30,601 New	30,601 $54,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.